A STUDY OF PROCEDURES FOR DOSSIER PREPARATION AND THEIR MARKETING AUTHORISATION IN DIFFERENT COUNTRIES OF SELECTED DRUG(S)
{ DOWNLOAD AS PDF }
ABOUT AUTHORS
1Veerendra Kr. Gautam*, 2Mohamad. Irfan
1Executive in Drug Regulatory Affairs Department; East African (India) Overseas
1 120 Suncity Business Tower,Sector-54, Gurgaon-122002 (Haryana).
2Research Associate; Jubilant Chemsys Ltd.
2D-12, Sector 59, Noida , Uttar Pradesh, India
1dra.veerendra.gautam@gmail.com;
1viren.gautam.dra@gmail.com 2mohd.irfan.ivar@gmail.com
Abstract : Dossier is a collection of documents on the particular subjects. Any preparation of pharmaceutical product for human use go through the process of reviewing and assessing the dossier of pharmaceutical product which contains details information about administrative, quality, non-clinical and clinical data. This process is governed and permitted by Drug Regulatory Authority of a particular country and process is called as NDA in USA, MAA in EU and other countries as simply Registration Dossier. There are basically two formats for dossier preparation i.e. ICH-CTD and ACTD. ICH-CTD followed by ICH countries as well as low economical or developing countries where as ACTD is followed by ASEAN countries. ACTD act as bridge between regulatory requirements of developed and developing countries. Also if both guidelines of CTD and ACTD can be harmonized then differences and variation between both guidelines can be minimized.